976 results on '"Socci, Nicholas D"'
Search Results
2. CDC7 inhibition impairs neuroendocrine transformation in lung and prostate tumors through MYC degradation
3. Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation
4. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
5. Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
6. Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia
7. The endogenous repertoire harbors self-reactive CD4+ T cell clones that adopt a follicular helper T cell-like phenotype at steady state
8. Ordered and deterministic cancer genome evolution after p53 loss
9. ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis.
10. An autoimmune stem-like CD8 T cell population drives type 1 diabetes
11. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
12. Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
13. Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
14. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation
15. Utility of circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) for prognosis of patients with recurrent high grade glioma.
16. Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use
17. Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer
18. Figure S2 from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
19. Supplementary Tables from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
20. Data from Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
21. ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
22. Supplementary Table S3 from PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
23. Data from PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
24. Supplementary Data 1 from PDGFRβ Signaling Cooperates with β-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis
25. Comprehensive evaluation of differential expression analysis methods for RNA-seq data
26. Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
27. PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression
28. Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation
29. PDGFRβ signaling cooperates with β-catenin to modulate c-Abl and biologic behavior of desmoid-type fibromatosis
30. Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma
31. Non-equilibrium raft-like membrane domains under continuous recycling
32. Tumour lineage shapes BRCA-mediated phenotypes
33. A study of accuracy and precision in oligonucleotide arrays: extracting more signal at large concentrations
34. Comprehensive genomic characterization of squamous cell lung cancers
35. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
36. Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
37. Supplementary Table 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
38. Supplementary Figure 6 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
39. Supplementary Figure 3 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
40. Supplementary Figure 4 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
41. Supplementary Figure 5 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
42. Supplementary Figure 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
43. Supplementary Figure 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
44. Tissue-specific features of the T cell repertoire after allogeneic hematopoietic cell transplantation in human and mouse
45. Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
46. Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
47. Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
48. Functional copy-number alterations in cancer.
49. Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
50. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.